GLP-2 TZ

GLP-2 TZ is a synthetic 39-residue peptide whose sequence corresponds to a chemically modified incretin backbone, the family that includes glucose-dependent insulinotropic polypeptide, abbreviated GIP, and glucagon-like peptide-1. The catalogue classes it as a dual GIP and GLP-1 receptor agonist peptide analogue: a single synthetic chain designed to carry affinity for two related class B G-protein-coupled receptors rather than one. Peptides of this class are commonly modified in two ways at once, by substituting non-natural residues at cleavage-sensitive positions and by attaching a fatty-acid moiety through a linker to a lysine side chain, both general strategies used to raise stability in in-vitro assays and to promote reversible albumin association.

The identifier recorded in the catalogue entry is the molecular formula, C225H348N48O68. A CAS registry number is not catalogued here and a molecular weight is not catalogued here, so neither value is stated. The full residue sequence and the positions of the modifications are likewise not recorded, and no sequence is asserted on this page. The material is listed under cell biology, is supplied lyophilized in a 10 mg vial, and carries no alternative catalogue synonyms.

Purity and identity are established by third-party HPLC and mass spectrometry, with a certificate of analysis for each lot. GLP-2 TZ is supplied strictly for laboratory research and is not for human or veterinary use, nor for consumption, administration, diagnostic use or therapeutic use.